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Climbing the Drug Staircase: 
A Bayesian Analysis of the Initiation of Hard Drug Use 
 
Empirical studies have found that cannabis commonly precedes consumption of drugs like 
amphetamine, ecstasy, cocaine and heroin. As a result a causal linkage between cannabis 
and subsequent hard drug use has been hypothesized. Despite mixed empirical evidence 
and a limited understanding of possible transmission mechanisms, the causal gateway 
hypothesis has been influential in formulating a strict drug policy in many western countries. 
Individual differences in proneness and accessibility, however, provide alternative, non-
causal explanations for the observed "staircase" pattern and yield potentially different policy 
implications. We propose a Bayesian estimation and predictive framework to analyze the 
effects and relative importance of previous cannabis use, proneness and accessibility factors 
on hard drug initiation and to explore potential policy implications, using data from a unique 
recent survey of young adults in Norway. Motivated by the gateway transmission channels 
proposed in the literature, our model allows for a constant and a heterogeneous effect of 
previous cannabis use on hard drug initiation and, also, a more flexible correlation pattern for 
the unobservables. We find that proneness, accessibility and previous cannabis use 
contribute to the observed higher drug use pattern among cannabis users. The latter has the 
largest effect and is driven by various transmission channels. 
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 1 Introduction
Cannabis is the most widely-used illicit drug in Europe, Australia and North America. Global
estimates suggest that currently there are about 160 million cannabis users and in many countries
prevalence numbers have risen over the last 10 years (UN 2007). An interesting question is
whether this widespread cannabis use will also lead to an increase in the number of hard drug
users. The question emerges because one of the most robust ¯ndings in the epidemiology of illicit
drug use is the initiation pattern, where most illicit drug users have started with legal drugs like
alcohol and cigarettes before proceeding to cannabis and subsequently, if further involvement
with illegal drugs, to hard drugs (Kandel 2002). For example, very few hard drug users go
straight to heroin without previously having used several other drugs and for many cannabis
was the ¯rst illegal drug used. Kandel (1975), employing a US sample, was the ¯rst to point
out this "staircase" but a similar pattern has been reported in many subsequent studies of drug
initiation (Kandel 2002).
The observed staircase pattern of illegal drug initiation has led to the so called gateway
hypothesis. It states that the use of cannabis increases the risk of using a hard drug such
as heroin and cocaine later on, i.e. it claims that there is a causal relationship running from
cannabis to hard drugs. By employing a number of di®erent econometric approaches empirical
work has examined whether such a causal e®ect exists. Some studies report evidence for a
\gateway" e®ect of previous cannabis use (e.g. DeSimone 1998, Fergusson et al 2006, Melberg
et al 2007 and Bretteville-Jensen et al 2008), while others (e.g. Pudney 2003, van Ours 2003,
Beenstock and Rahav 2002) ¯nd only weak or no support for such an e®ect. Despite the mixed
and limited evidence for a gateway e®ect, the hypothesis has been in°uential in formulating a
strict drug policy in many western countries and opponents of decriminalizing cannabis often
refer to the assumed causal relationship in their argumentation.
Proneness and Accessibility have been suggested as two alternative non-causal explanations
for the observed correlation between cannabis and hard drug use and may lead to new policy
implications. Proneness refers to personal factors that lead to a predisposition towards \problem
behaviour" (Pudney 2003). Such proneness to deviant behavior may lead some subjects to
2consume illicit drugs, and cannabis is just used prior to others because it is cheaper and more
readily available. Excessive drug use is then viewed as one out of many potential undesirable
behavioral responses to e.g. unfavorable genetic endowments or traumatic childhood experiences.
If people with this vulnerability have an increased risk for drug use, there may be no causal link
between cannabis and hard drugs that explain the familiar initiation pattern (Morral et al.
2002).
Accessibility refers to a subject's economic, cultural and physical access to drugs and a®ects
a subject's monetary costs and non-monetary costs of drug use, such as transaction costs and
social stigma. Economic theory would predict a higher probability of drug uptake for subjects
with better access (lower costs). Accessibility is likely to vary between youngsters. Some may
have better knowledge of how and where to obtain drugs, what prices to pay etc. since, for
example, drug use is more accepted in some youth cultures than others. If cannabis users are
those subjects who tend to have lower costs of hard drug use this would contribute to the
observed pattern of higher hard drug use in this group.
In this paper we investigate the role of proneness and accessibility in addition to that of
previous cannabis intake on an individual's decision to initiate hard drug use. Detailed drug use
data with information on both proneness and accessibility are rare. As a result little has been
said about the e®ect of proneness and accessibility in recent gateway studies, which mainly rely
on econometric techniques to isolate the gateway e®ect of previous cannabis use from that of
unobserved proneness and accessibility. Exceptions include Pudney (2003) who uses prevalence
indices (based on six seizures, drug-related convictions and prevalence rates indicators) and
Melberg et al. (2007) who employ drug prices. For our analysis we exploit a unique survey of
young Norwegians in 2006 that collected detailed data on drug use and initiation patterns, and
also provides subject-level information on drug accessibility and proneness.
Secondly, we also investigate possible channels for the gateway e®ect as a drug policy, aiming
at reducing hard drug use, will depend not only on the role of accessibility and proneness factors
versus a possible gateway e®ect, but also on the mechanisms that mediate a gateway e®ect of
cannabis. A number of possible transmission mechanisms channels have been suggested (see
3e.g. Pudney 2003, Melberg et al. 2007): 1) the use of cannabis may create a psychological or
physiological need for stronger narcotic experiences; 2) personal experiences with cannabis may
reduce the credibility in warnings against hard drugs; 3) having used one illegal drug may lower
the threshold for trying other illegal drugs; 4) obtaining and using cannabis may induce contact
with hard drugs users and dealers whom they would not otherwise have met. Channels 2 and
3 imply lower costs of hard drug use for cannabis user. This suggest a possible identi¯cation
strategy for these channels as we can exploit the fact that a cannabis user would be more likely
to move on to hard drugs than a non-users given the same cost of use (accessibility).
We base our empirical analysis of the gateway, proneness and accessibility e®ects on a bi-
variate probit model of hard drug initiation and previous cannabis use that has features of an
endogenous switching regression model. The modeling framework relaxes two common assump-
tions made in the previous empirical work: (1) constant gateway e®ect; and (2) same correlation
pattern of the unobservables for all subjects. Our model is formulated within the Bayesian
paradigm. We exploit information from a similar (but more restrictive) 2002 survey of young
Norwegians to formulate our prior assumptions about the model parameters. We employ the
Bayesian predictive approach to analyze the relative importance of the three e®ects on the prob-
ability of hard drug initiation. We estimate the marginal predictive probabilities of hard drug
uptake under no and previous cannabis intake to quantify the e®ect of previous cannabis use and
compute, for example, average marginal e®ects of accessibility, proneness and previous cannabis
use. We also use the predictive approach to investigate various policy relevant scenarios.
The estimation of the model and the predictive analysis are based on Markov Chain Monte
Carlo simulation methods, thus avoiding a solution via the optimization of the likelihood which
can be challenging in such problems. Another advantage of the Bayesian predictive approach is
that the predicted probabilities are based on the posterior distribution of the parameters rather
than point estimates. Given the limited availability of strictly exogenous control variables in
this type of problems a number of coe±cients are estimated with a lower precision as re°ected
in the variance of the posterior distributions of the model parameters. In the predictive analysis
under the Bayesian paradigm this imprecision is accounted for directly according the posterior
4distribution of the model parameters. Suitable Markov Chain Monte Carlo methods for the
model ¯tting and predictive analysis are developed in the paper, building on work by Chib
(2007) and Chib and Jacobi (2007).
Overall, a robust ¯nding that emerges from our analysis is that proneness, accessibility and
previous cannabis use contribute to the observed higher drug use pattern among cannabis users.
The latter has the largest e®ect and is driven by various transmission channels.
2 Data
2.1 The Survey
In 2002 and 2006 the Norwegian institute for alcohol and drug research (SIRUS) sent postal
questionnaires to a representative sample of young adults to collect data about the respondents'
legal and illegal drug use. In this paper we employ the most recent of these surveys which
includes data on ethnicity and for which we can construct price variables. The rich data set
provides information on the frequency of current and life time drug use, as well as on the starting
ages for the various drugs. In addition to personal characteristics, several variables related to
proneness and accessibility to various drugs are available for each respondent. The survey was
aimed at the population between the age of 21 and 30. This age group is particularly well suited
for the analysis of illicit drug use behaviour, as these and other data show that most recreational
drug users have started drug use by the age of 21 and that frequency and extent of drug use is
highest among young adults.
The response rate of the 2006 mail survey was 43 per cent, which is roughly in line with other
studies of this type (see e.g. Reinarman et al. 2004). Only one reminder was sent to everyone.
Our net sample consists of 4164 observations. Compared to another Norwegian data set that
includes the same age group (see Horverak 2006 for details), the life-time prevalence rates for
the di®erent drugs are slightly higher in the present sample but within the same range (e.g.
32.5% vs 29.0% for cannabis). The lower rates in the other data set may be due to di®erences
in data collection methods as it was based on face-to-face interviews for questions related to
alcohol and a self-administered questionnaire for illegal drugs. A longitudinal study based on a
5representative sample of students in 1992 (mean age was 15 years) that were followed to 2005
also shows comparable prevalence rates for drug use (Pedersen 2008).
It is well known, however, that various sub-groups (institutionalized people, intravenous/heavy
drug users etc.) are likely to be under-represented in net samples from national surveys as these
groups are harder to reach and may be less willing to ¯ll out a questionnaire. Our ¯ndings may
thus be more relevant for the group of recreational users of illicit and licit drugs than for the
group of problematic drug users.
Figure 1 shows the initiation pattern of drug use in terms of the mean starting ages for alcohol
and the main illegal drugs (cannabis, amphetamine, heroin, ecstasy and cocaine, respectively)
in our sample. The graph re°ects the commonly reported initiation pattern for drug use with



























Figure 1: Starting ages for alcohol and various illegal drugs in the 2006 SIRUS survey.
cannabis being the illegal drug with the lowest starting age. The mean age of starting with
alcohol is 15.4 which is well below the mean starting ages for illegal drugs: 18.1 for cannabis;
19.2 for amphetamine; 19.3 for heroin; 19.4 for ecstasy and 20.5 for cocaine. Since this paper is
primarily concerned with a subject's involvements in the illegal drug market beyond cannabis
use, we follow Melberg et al (2007) and merge the heroin, amphetamine, ecstasy and cocaine
use variables into one hard drug use variable. All these drugs score higher than cannabis on
"mean physical harm" and "acute harm" in a ranking made by a group of drug experts (Nutt et
6al. 2007). Further, the majority of the hard drug users in the survey (65%) report to have used
more than just one of these drugs. For example, among the 294 ecstasy users in the sample,
89% have used at least one other hard drug (see Table 7 in the appendix).
The sampling procedure employed by SIRUS implies an over-sampling of people from the
capital city, Oslo. This increases the overall prevalence of drug use as young people in Oslo
use more drugs than do people from comparable age groups outside the capital but should not
otherwise a®ect the sample. In general, illegal drug use in Norway falls into the general pattern
observed in other Europe countries. For instance, according to national surveys of 15-34 year
olds published by the European Monitoring Centre for Drug use and Dependence (EMCDDA
2007) the life time cannabis use in Norway (25.5%) is lower than in e.g. Denmark (49.5%), U.K
(42.3%), France (43.6%) and the Netherlands (32.3%), but higher than e.g. in Sweden (19.1%)
and Finland (22.0%). According to a recent report from the United Nations, cannabis use in
Europe is less prevalent in Oceania and North America (UN 2007).
Good and reliable data on illicit drug use is di±cult to obtain. General population surveys,
like the present, are based on self-reported information may, for example, su®er from false nega-
tives (drug users claiming not to have used illegal substances or reporting a lower consumption
level or frequency than the real one) and/or false positives (people exaggerating their actual
drug use). For phenomena with low frequency, like heroin use, the false positives are considered
a bigger problem than the false negatives (Skog 1992). We have no means to test for false nega-
tives. However, the reported prevalence of the non-existing drug \relevin" gives an indication of
false positives in the present sample. \Relevin" was listed as just another drug the respondents
were asked about and with only 9 people in the sample (0.2 per cent) reporting to have ever
used this particular drug, false positives does not seem to be a pervasive problem in our data.
Since the data is based on a younger cohort it is reasonable to assume that recall bias is less of a
problem compared to studies including people in their 40-60s. For most subjects in these older
cohorts drug initiation would have occurred two or more decades before the time of the survey.
72.2 Drug Use, Accessibility and Proneness in the Data
Drug users were asked to report their frequency of illicit drug use (the categories were 0, 1-4,
5-10, 11-25, 26-50, 50+). Life time prevalence of cannabis use in the current sample is 38.2
per cent. Many subjects report to have tried cannabis less than ¯ve times. It is questionable,
however, whether using cannabis once or a few times only is su±cient to cause an e®ect on hard
drug use. For our main empirical analysis we assume that for cannabis to have an e®ect on
further drug involvement a life time frequency of 5 or more times is required, and categorize
\incidental" cannabis users (1-4) as non-users of cannabis. We relax this assumption in our
sensitivity analysis. In the case of hard drug use, we de¯ne a subject as a users if any hard drug
has been use at least once (including subjects from 1-4 category). Using a hard drug just once
increases the risk of adverse health e®ect (heroin overdosing etc.). Given these de¯nitions, the
cannabis prevalence in the sample is 23.4% and the hard drug prevalence is 13.7%. Among the
973 cannabis users, 48% (n=469) have also used hard drugs, while 18% of the 571 hard drug
users (n=102) do not report any previous cannabis use.
Table 1 presents a summary of the sample means for relevant demographic, proneness and
accessibility related variables by three di®erent drug use states: no drug use; cannabis use only;
hard drug use. We observe little variation in the age of subjects in the three groups: 29% of the
sample respondents that have used no illegal drugs or only cannabis are 24 years or younger at
the time of the interview compared to 27% of the hard drug users. The proportion of males,
however, increases with drug involvement from 36% among the non-users to 52% among the
hard drug users.
The data set provides several variables that can be taken as proxies for proneness to drugs.
For example, the respondents were asked \When thinking back to your childhood, would you
say that you had any serious problems with parents, school, friends or police?" The term
\childhood" is not speci¯cally de¯ned in the questionnaire. In accordance with the proneness
hypothesis, Table 1 shows that these indicators have higher means among hard drug users than
among the other two groups. Very few subjects in the non-user and cannabis-only categories
report any problems with police (less than 1 per cent), compared to 6 per cent among the hard
8Variable No Drug Use Cannabis (only) Hard Drugs
Description [short] (n=3,089) (n=504) (n=571)
Demographics
Male [male] 0.36 0.43 0.52
Age between 21-24 years [age2124] 0.29 0.29 0.27
Proneness
Childhood problems with Police [police] 0.007 0.004 0.06
Childhood problems with Parents [parents] 0.06 0.10 0.20
Childhood problems in School [school] 0.04 0.07 0.13
Childhood problems with Friends [friends] 0.03 0.04 0.06
Leave School after year 10 [leaveschool] 0.04 0.04 0.12
Alcohol used before age 13 [alcyoung] 0.04 0.10 0.16
Smoker [smoke] 0.45 0.86 0.84
Accessibility
Non-western cultural background [nonwest] 0.06 0.02 0.04
Living in the Country [country] 0.42 0.24 0.27
Obtain cannabis [obtaincan] 0.54 0.55 0.55
Obtain hard drug [obtainhard] 0.42 0.43 0.43
Cannabis prevalence [prevcan] 0.23 0.25 0.25
Hard Drug prevalence [prevhard]
# of heroin seizures [seizure] 294 366 374
Cannabis price [canprice] 101 100 101
Amphetamine price [amhprice] 542 539 545
Living in Oslo [oslo] 0.50 0.66 0.67
Table 1: Summary of key variables of 2006 sample of the SIRUS data by drug intake.
drug users. Problems with parents and school show an increasing trend when moving from non-
users to hard drug users, with the latter group reporting three times the prevalence of non-users.
Further, a larger proportion of hard drug users report problems with friends during childhood
(6%) than did cannabis-only and non-users of drugs. The large majority of young adults (86%),
however, did not claim any of the listed childhood problems problems and most of those who
did only reported one type of problem (68% of 578 individuals, see Table 8 in the appendix).
Table 1 further reveals that the group of illicit drug users has a much higher proportion
of respondents that started with alcohol at a very young age (< 13 years) and who dropped
out of school after only 10 years (at the age of 15/16). Starting with alcohol before turning
13 or leaving school at an early age could be signs of a deviant personality, re°ect adverse
personal experiences or suggest a relatively high time preference rate. According to the \theory
of rational addiction", the latter also increases the probability of problematic drug use (Becker
and Murphy 1988). Finally, given the well-known health risks associated with cigarette smoking
we will include a dummy for smoking (set equal to 1 if ever smoked with some regularity) and
9use this as an additional proneness proxy.
In addition to individual proneness, we also consider a subject's accessibility (cultural, eco-
nomic and/or physical) to drugs to be an important determinant of drug use. The survey
provides information on various aspects of accessibility that are related to monetary and non-
monetary costs of cannabis and hard drug use. For example, the drug using culture among
non-western immigrants may di®er from that of native Norwegians. Table 1 shows that the
highest proportion of non-western immigrants is found among the non-users. Respondents liv-
ing in cities may have easier access (both physical and cultural) to drugs compared to subjects
living in more remote rural areas of Norway. The distribution of the dummy variable \country"
(equal to one if the respondent lives outside one of the three main cities in Norway) across the
three groups of users in Table 1 is in line with this view as the proportion of urban people is
higher among the two groups of illicit drug users. A further inspection of the data reveals that
a larger proportion of respondents living in cities claim to be able to obtain illegal drugs within
3 days (72% vs 57%) and have been o®ered illegal drugs (78% vs 59%). The obtain variable
also di®ers substantially by cannabis intake (see Table 8 in the appendix). Employing these
variables directly, however, may cause severe endogeneity issues. Instead we use the individual
obtain information to create location speci¯c obtain variables for cannabis and hard drugs. The
obtain variables in Table 1 are de¯ned as the percentage of non-users that can obtain cannabis
or hard drugs within 3 days in each of the 19 counties in Norway. As an additional indicator
of cultural accessibility, we have included variables for the mean county prevalence of cannabis
and hard drugs. Even though the \prevalence" and the \obtain" variables do not show much
variation across the groups in Table 1, we ¯nd in our empirical analysis that they in°uence the
cannabis and hard drug uptake (see Table 2). An important variable that directly relates to
the economic accessibility is a person's income. Unfortunately, the survey only contains current
income information for survey respondents, and no historic information on the personal, par-
ents' or family income at the time of the drug initiation. Also, a quarter of the respondents are
students at the time of the survey.
Accessibility related data from two supplementary data sources have also been included. The
10\seizure" variable is based on the mean number of amphetamine and heroin seizures by customs
and police for each county. In our analysis we use this variable as a proxy for the geographical
variation in hard drug supply. Table 1 shows that hard drug users live in areas with the highest
number of seizures per 100,000 inhabitants. Finally, previous research on cannabis use indicates
that drug prices are potentially important in explaining drug use as they are a direct measure
of monetary costs of drug use (Van Ours and Williams, 2007). Given the illegality of drug
markets, reliable and detailed price data are rare. We are fortunate to have data on cannabis
and amphetamine prices that were collected through personal interviews with drug addicts.
Since 1993 more than 4000 interviews have been conducted with people attending the main
needle exchange service in Oslo (see Bretteville-Jensen and Biorn (2004) for more details of this
data collection). The prices for hard drugs have shown a falling trend throughout the period
and the amphetamine price series is used as a proxy for all hard drug prices. Since we have
cross-sectional data, every person is assigned the cannabis and amphetamine price that prevailed
when he/she statistically had the highest risk of taking up the di®erent drugs (drug price and
seizure variables are divided by 1000 in the estimations). We include a dummy for Oslo in our
empirical analysis as the police reports that drug prices outside the capital are higher. However,
this dummy would also capture di®erences in cannabis or hard drug culture in Oslo compared
to other parts of Norway.
3 Empirical Analysis
3.1 Model Speci¯cation
In this section we formulate a model to investigate the e®ect of prior cannabis use, accessibility
and proneness factors on hard drug initiation in the Norwegian drug use data. In the literature
a subject's binary hard drug intake hi = 0;1 is commonly speci¯ed as a function of a vector of
(mostly demographic) variables wi and an indicator ci = 0;1 of a subject's cannabis use prior to
his or her hard drug initiation. If we let h¤
i denote the underlying continuous latent hard drug
initiation variable such a model for hard drug initiation can be written as
h¤
i = ®0 + w0
i® + ®cci + "i
11where hi = I[h¤
i > 0]. Assuming a normal link function, "i » N(0;1), the speci¯cation implies
a probit model for hi. The coe±cient ®c is commonly interpreted as the gateway e®ect of
cannabis use on hard drug initiation. While it can be disputed under what conditions this
coe±cient can be interpreted as a causal e®ect, we will follow the literature and refer to it
here as the constant/direct gateway e®ect. Since it is not possible to rule out the presence of
unobserved factors that a®ect both a subject's probability to use cannabis as well as harder
drugs, the recent literature has treated ci as an endogenous regressor.
We propose a modeling framework in terms of °exible bivariate probits with features of an
endogenous switching regression model. We specify a bivariate probit model for the hard drug
initiation hji = l and previous cannabis use ci = j of the ith subject, where l;j = 0;1. The
notation hji emphasizes that the model for hard drug initiation will depend on the subject's
previous cannabis use, indicated by the subscript j. We specify the marginal models for binary
hard drug initiation and previous cannabis use in terms of the latent variables as
h¤
ji = ®0 + w0
ah;i ¯j + ci®c + w0
p;i ®p + w0
d;i ®d + "ji ; ci = j (3.1)
c¤
i = °0 + w0
ac;i °a + w0
p;i °p + w0
d;i °d + ui (3.2)
where hji = I[h¤
ji > 0] and ci = I[c¤
i > 0]. The error terms are jointly normally distributed, as









The covariate vectors for accessibility, proneness and demographic factors are de¯ned in terms
of the variables described in Table 1 as
wah;i = [country, oslo, obtainhard, seizure, prevhard,nonwest,amphprice]
wp;i = [police, parents, school, friends, leaveschool, alcyoung, smoke]
wd;i = [male, age2124]
wac;i = [country, oslo, obtaincan, prevcan, nonwest, canprice]:
The model extends the standard framework to consider the role of proneness and accessibility
factors on drug initiation and relaxes two restrictive assumptions. First the model relaxes the
12assumption of a constant/homogeneous (gateway) mean e®ect of previous cannabis use on hard
drug initiation. Hard drug initiation (3.1) is now modeled as a function of accessibility factors
(wah;i), proneness factors (wp;i) and previous cannabis use. Previous cannabis use a®ects the
mean of the hard drug initiation model through (i) a constant e®ect modeled (®cci) and (ii)
through interaction with the vector of accessibility factors (w0
ah;i ¯j). Our model thus implies
that the overall e®ect of prior cannabis use on hard drug initiation is captured by a constant
e®ect and heterogeneous e®ect which are motivated by the di®erent transmission channels. The
latter heterogeneous e®ect is identi¯ed through di®erent coe±cient vectors on the accessibility
variables, ¯0 for subjects with no previous cannabis use and ¯1 for subjects with previous
cannabis use. The constant/homogeneous and heterogenous e®ects of previous cannabis use on
hard drug initiation can be identi¯ed since we have kept the assumption of a common intercept
®0. We refer to the composite e®ect of previous cannabis use as the extended gateway e®ect in
the remainder of the paper and to this model as the \Extended Gateway model".
There are several reasons why one may wish to relax the assumption of modeling the e®ect of
previous cannabis use through only a constant \gateway" e®ect and proceed with our proposed
speci¯cation. First, as the discussion in the introduction highlights, there are at least four
possible transmission channels how cannabis use may a®ect a subject's likelihood of hard drug
initiation: 1) creates psychological or physiological need for stronger narcotic experiences; 2)
reduces credibility in warnings against hard drugs; 3) lowers threshold for trying harder drugs;
4) leads to better contact and knowledge about the hard drug market. Second, we are interested
in exploring the role of proneness and accessibility factors on hard drug initiation. If cannabis
use a®ects hard drug initiation through channels (2) and (3), this would imply that subjects
with previous cannabis use are more likely to initiate hard drug use given the same cost of hard
drug initiation as measured by cultural and physical accessibility factors. We have therefore
modeled the e®ect of accessibility as a function of a subject's previous cannabis use. In the
presence of channels (2) and (3) we would expect to see di®erent posterior distributions for the
coe±cients in ¯0 and ¯1. We still include a constant e®ect of previous cannabis use measured
by ®c to capture channels (1) and (4). A posterior distribution of ®c with a positive mean would
13be a support for either one or both of these channels.
Second, our modeling framework relaxes the assumption of the same unobserved correlation
patterns between cannabis and hard drug use for all subjects (for example cannabis users and
non-users). The raw data shows that cannabis users and non-users di®er signi¯cantly in terms
of their observed characteristics and thus, very likely also in terms of their unobserved factors
that a®ect cannabis and hard drug initiation. For example, we cannot rule out that cannabis
users di®er in terms of their unobserved proneness characteristics or socioeconomic background
from the non-cannabis users in the population. These factors may a®ect cannabis and hard
drug uptake, but not necessarily in the same way, which can be captured by di®erent correlation
pattern for cannabis users and non-users.
Another interesting feature of our modeling approach is that we exploit the information on
accessibility and proneness factors in the modeling of cannabis initiation (3.2). By modeling
previous cannabis intake in such a way we obtain a benchmark for the interpretation of the
coe±cient estimates from the hard drug model and also a more di®erentiated picture of hard
drug versus cannabis use.
To benchmark our coe±cient estimates for the constant gateway e®ect, we also consider
a simpler speci¯cation of the hard drug model similar to those in previous work and only
include a constant gateway e®ect of cannabis use (\Restricted Gateway Model"). In our model
speci¯cation (3.1) this would be re°ected by setting ¯0 = ¯1. Note that while it would be
theoretically possible to ¯t a fully °exible hard drug model where all coe±cient vectors depend
on previous cannabis intake, this would not allow us to identify the coe±cient on the constant
gateway e®ect as the e®ect would be subsumed in the intercept. In addition, the very low
prevalence of some proneness variables in the group of non-drug users would make it very
di±cult to identify ®
p
j.
Finally, to express our joint model for hard drug initiation and previous cannabis use more
compactly and to aid our formulation of prior parameters, we de¯ne the parameter vectors
® = f®0;®a;®p;®dg, ° = f°0;°a;°p;°dg and the covariate vectors w1;hi = [wah;i] , w2;hi =
[const;ci;wp;i;wd;i] and wci = [const;wac;i;wp;i;wd;i]. We can now write the joint model for










1;hi £ (1 ¡ j) w0
1;hi £ (j) w0
2;hi 0




and ± = (¯0;¯1;®;°).
3.2 Prior-Posterior Analysis
In the Bayesian estimation framework all information about the vector of model parameters,
µ = (¯0;¯1;®;°;½0;½1), is summarized in the posterior distribution of the model parameters
conditional on the observed data ¼(µjh;c;W). The posterior distribution combines the infor-






Pr(hji = l;ci = jjWi;µ) (3.4)
and prior knowledge about the parameters expressed in the prior distribution ¼(µ). From the
modeling assumptions in the previous section it follows directly that the likelihood contribution















where l = 0;1, and the integration regions are f¡1;0g for l;j = 0 and f0;+1g for l;j = 1.
The prior posterior analysis provides us with a tool to incorporate prior knowledge about
the model parameters via the prior distributions of the parameters, ¼(µ). To formulate our
prior assumptions we ¯rst follow standard practice and specify normal prior distributions for
the slope parameters and the correlation coe±cient. For the correlation coe±cient the normal
prior is restricted to the region R = f¡1 < ½j < 1g to ensure the positive de¯niteness of
the correlation matrix ­j. Assuming that the parameters are apriori independent, the prior
15distribution of the coe±cient vector, µ is given by
¼(µ) = Nm(®ja0;A0) Nq(°jg0;G0)
1 Y
j=1
Np(¯jjbj0;Bj0) N(½jjrjo;Rj0) £ R: (3.5)
Since the speci¯c problem and data has not been previously analyzed in the literature we use
information from the 2002 drug survey of SIRUS to help specify the parameters in the prior
distributions (see appendix for details).
The posterior distribution of the parameters is proportional to the product of the likelihood
(3.4) and the prior (3.5). Given the structure of the likelihood it is not available in closed
form and we develop an estimation algorithm based on Markov Chain Monte Carlo methods
to generate draws from the posterior distribution. We employ the approach from Albert and
Chib (1993) to deal with the binary variables by including the latent drug use variables into the
parameter space. The details of the algorithm are given in the appendix. Of particular interest
for our analysis are inferences based on the marginal posterior distribution of each parameter.
Fortunately, by construction of the MCMC algorithm, the draws for each parameters come
from the marginal posterior distribution of that particular parameter, which can be used to
summarize the corresponding marginal posterior distributions of the model parameters. Usually
this is done in terms of the means and standard deviations of the marginal posterior distribution
and/or directly in graphical form.
3.3 Predictive Analysis
While the inferences about coe±cients from the prior-posterior analysis will provide us with
some information about the e®ects of the accessibility and proneness related variables and pre-
vious cannabis use on hard drug initiation, the coe±cients of the probit model are not easily
interpreted. Further, the coe±cient estimates will not allow us to assess the overall impact of
the observed accessibility and proneness related factors on a subject's probability of hard drug
uptake compared to that of previous cannabis use. To address this issues we employ a predictive
analysis of the probability of hard drug uptake.
The predictive approach enables us to draw inferences about the hard drug initiation of a
random future observation from the population (denoted with n + 1). It will be based on our
16observed sample data (c;h;W) and the inferences about the model parameters summarized
in the posterior distribution of the model parameters (from the model ¯tting). In this paper
we are particularly interested in the probabilities that a random subject from the population
will initiate hard drug uptake under no and previous cannabis use. We then explore how these
probabilities are a®ected by accessibility and proneness related factors. We also explore the
constant/direct e®ect of prior cannabis use on the probability of hard drug initiation.
The marginal predictive probabilities of hard drug use Pr(hj;n+1 = 1jc;h;W), j = 0;1 can
be computed based on the marginal predictive distribution of the latent hard drug intake for a
subject as
Pr(hj;n+1 = 1jc;h;W) = Pr(h¤
j;n+1 > 0jc;h;W) (3.6)
We compute this quantity of interest from the marginal distribution of hard drug intake con-
ditional on the model parameters p(h¤
j;n+1jh;c;W;wh;n+1;¯j;®) by integrating over the model
parameters using the posterior distribution of the model parameters from the model ¯tting and
over the covariates using the empirical distribution from the sample (see appendix for details).
To see how we use the predictive approach to assess the e®ect of accessibility, proneness





j;n+1jh;c;W;wh;n+1;¯j;®)¼(¯j;®jh;c;W)p(wh;n+1jh;c;W) d¯j d® dwh;n+1
where the ¯rst expression is the conditional predictive distribution, ¼(¯j;®jh;c;W) is the pos-
terior distribution of parameters in the marginal probit models for hard drug initiation and
p(wh;n+1jh;c;W) the empirical distribution of the covariates in the vector. The conditional
predictive distribution is just the likelihood of the future observation n+1, given by the marginal
model for latent hard drug intake h¤
j;n+1 by expression 3.1. From the model assumptions in Sec-
tion 3.2 it follows that it is given by a normal distribution N(h¤
j;n+1j¹j;n+1;1) where the mean
is a function of cultural and physical accessibility factors, prices, proneness and demographic
factors:
¹j;n+1 = ®0 + w0
ah;n+1 ¯a
j + ®ccn+1 + w0
p;n+1 ®p + w0
d;n+1 ®d
17where j = 1 refers to cn+1 = 1 and j = 0 to cn+1 = 0. To assess how a subject's probability of
hard drug uptake is in°uenced by the three factors we also compute the predictive probabilities
setting ¯a
j = 0, ®c = 0 or ®p = 0 (see Table 3). Comparing the obtained predictive probabilities
without the e®ects of observed accessibility with the total predictive probability allows us to
evaluate the average marginal e®ect of accessibility in predicting a subject's hard drug uptake.
For example, estimating the partial predictive probability for j = 0;1 under ®p = 0 the di®erence
to the predictive probability can be interpreted as the average marginal e®ects of proneness on
hard drug initiation under no and previous cannabis use. Since this calculation can only be
based on observed accessibility, these results should be interpreted with care and understood
more as a lower limit of the role that accessibility factors play in a subject's hard drug uptake.
4 Estimation Results
4.1 Results from Prior-Posterior Analysis
In this section we discuss the results from the prior-posterior and predictive analysis of the
Norwegian drug use data based on the extended gateway model that we described in the previous
section. Table 2 provides a summary of the estimation results for the extended gateway model
in terms of the means and standard deviations of the posterior distributions of the parameters.
Our results are based on 10,000 iterations of the MCMC algorithm (described in detail in the
appendix after) a burn-in phase of 1,000 iterations. For comparison, we also provide selected
results from the ¯tting of a more restricted model with only a constant e®ect of previous cannabis
use on hard drug uptake (restricted gateway model).
A comparison of the means of the posterior distributions of the coe±cients on the accessibility
factors in the hard drug model (¯rst block in columns 2 and 3) indicates that accessibility a®ects
hard drug initiation and that the e®ect varies by previous cannabis use. For example, we see
that living in the country increases the likelihood of a cannabis user to take up hard drugs,
as does living in an area with high supply (seizure), high prevalence and being of non-western
background. The latter has a negative e®ect for non-cannabis users as does living outside Oslo.
The e®ects of the remaining accessibility variables are small and estimated with a lower precision
18Extended Gateway Model Restricted Gateway Model
Hard uptake Can uptake Hard uptake
no can can
Country 0.12 (0.19) 0.37 (0.18) -0.27 (0.10) 0.17 (0.14)
Oslo 0.46 (0.28) -1.11 (0.46) -0.03 (0.11) -0.06 (0.25)
Obtain 0.48 (0.99) -0.02 (1.06) 0.15 (0.71) 0.05 (0.75)
Seizure 0.11 (0.67) 3.21 (1.11) - 0.97 (0.61)
Prevalence 0.20 (1.31) 2.46 (1.97) 2.26 (0.91) 1.47 (1.23)
Non-Western -0.31 (0.19) 0.48 (0.29) -0.54 (0.13) -0.08 (0.15)
Amphetamine Price 0.47 (0.41) 0.04 (0.45) - 0.23 (0.35)
Cannabis Price - - -0.62 (1.38) -
Cannabis Use 1.20 (0.54) - 1.10 (0.41)
Police prob. 0.90 (0.22) 0.62 (0.19) 0.89 (0.21)
Parents prob. 0.45 (0.11) 0.42 (0.08) 0.46 (0.10)
School prob. -0.02 (0.13) 0.25 (0.11) 0.01 (0.13)
Friends prob. -0.04 (0.16) -0.09 (0.13) -0.02 (0.15)
Leave School early 0.52 (0.12) 0.19 (0.11) 0.50 (0.12)
Alcohol young 0.28 (0.11) 0.41 (0.09) 0.31 (0.11)
Smoker 0.42 (0.15) 1.17 (0.06) 0.41 (0.16)
Male 0.28 (0.07) 0.43 (0.05) 0.28 (0.08)
Age2124 -0.01 (0.10) 0.03 (0.06) -0.02 (0.09)
Intercept -2.81 (0.48) -2.27 (0.39) -2.65 (0.37)
Correlation 0.34 (0.23) 0.06 (0.20) 0.26 (0.14) 0.15 (0.21)
Table 2: Posterior means and standard deviations (parentheses) for parameters in the cannabis
and hard drug equation from the prior posterior analysis of the extended gateway model and the hard
drug equation from the restricted gateway model.
for non-cannabis users as indicated by the high posterior standard deviation. The low precision
is not surprising as there is only a small number of hard drug users without previous cannabis
use in the data (n=102). Further, our estimates show almost no e®ect of amphetamine price
on the probability of hard drug uptake of cannabis users (posterior mean of 0.04 and standard
deviation of 0.45), while the e®ect is positive for non-users (posterior mean of 0.47) but also
estimated with a low precision (posterior standard deviation of 0.41).
For previous cannabis use (column 4) the coe±cient on cannabis price is negative, but also
imprecisely estimated. This suggests that prices (as measured here) are not of great importance
for drug initiation. However, we cannot rule out that this is, at least partly, due to the poor
data situation (only data for Oslo is available) and to how the price variable is constructed.
For example, van Ours and Williams (2007) ¯nd a negative e®ect of cannabis price on cannabis
initiation. The remaining coe±cient estimates for the accessibility variables in the cannabis
19model suggest that accessibility factors also matter for cannabis intake. Cannabis prevalence
and obtainability have a positive e®ect on cannabis use while being of non-western cultural
background and living in the country has a negative e®ect. We ¯nd no e®ect for living in Oslo.
For hard drug initiation we found a positive coe±cient for the Oslo variable under no previous
cannabis use and a negative e®ect under previous cannabis use. The latter might suggest that
a cultural acceptance of cannabis use in Oslo (larger prevalence of cannabis use in Oslo in the
raw data) does not translate into a cultural acceptance for hard drug use.
We now turn to the estimates of the constant/direct e®ect of previous cannabis use and
proneness factors. Table 2 shows a large positive coe±cient for previous cannabis use on the
probability of hard drug initiation. We also ¯nd positive coe±cients for childhood problems
with police and parents, leaving school early, early alcohol use and smoking. These factors also
increase the likelihood of cannabis use. In contrast, problems in school and with friends do not
seem to have an e®ect on hard drug initiation. We ¯nd similar results for the coe±cients on
previous cannabis use and the proneness variables in the hard drub model in our estimation of
the restricted model that only for a constant e®ect of previous cannabis use (see last column of
Table 2). However, this is not the case for the coe±cients on the accessibility and price variables.
We see that the coe±cients on Oslo, Non-Western and the price variables are now close to zero.
Except for living in the country, which has a positive e®ect, the coe±cients on the remaining
variables are estimated with a low precision.
We have set up our model to allow for di®erent correlation patterns between the unobserv-
ables in the models for hard drug initiation and previous cannabis use in the sub-populations
of drug users and non-users. We do observe di®erences in the estimated correlation patterns for
the two groups. The posterior mean and standard deviation for the correlation coe±cients (½j)
for our extended gateway model and also the restricted model are shown in the last row in Table
2. We observe positive posterior means for ½0 and ½1 in both models. In the extended gateway
model the posterior mean for non-users of cannabis exceeds that of cannabis users by more than
¯ve times (less than two times in the restricted model) and the latter is very small. Previous
work that has used a more restrictive model formulation for hard drug use and the correlation
20structure has found a positive correlation for the overall population (Bretteville-Jensen et al
2008), and under such restrictions we too estimate a positive correlation for both groups.
For a more detailed summary of the accessibility related coe±cients in the hard drug model
we take a closer look at the posterior distributions of the accessibility coe±cients from the
extended gateway model. In Figure 2 we provide plots of the posterior distributions of the
coe±cients for the accessibility variables in vectors ¯0 and ¯1. The solid line refers to no
previous cannabis use and the dashed line to previous cannabis use. Except for the case of
the obtain variable (Plot c), the two lines have di®erent regions of support (some overlapping).









































































Figure 2: Plots of the posterior distributions of the coe±cients for Oslo, prevalence and non-western
under no cannabis use (solid line) and cannabis use (dashed line).
a constant gateway e®ect) as it shows that the impact of most accessibility variables on hard
drug uptake depends on previous cannabis use. We therefore proceed with our further analysis,
including the predictive analysis and policy analysis in the following sections, under the extended
gateway model. In the next section we perform a sensitivity analysis of the extended gateway
model and consider a range of alternative model speci¯cations, e.g. alternative de¯nitions for
21the dependent variables and alternative vectors of covariates.
Note that our estimates for the accessibility variables in the two hard drug models, presented
in Table 2 and Figure 2, are interesting with regard to the possible transmission mechanisms
of cannabis use. In particular, the fact that physical accessibility, measured by the seizure and
prevalence variables, has a large positive e®ect under previous cannabis use compared to almost
no e®ect under no previous cannabis use may suggest that having used cannabis lowers the
threshold and the perceived risk of using hard drugs (transmission channel 2 and 3). Further,
we ¯nd that previous cannabis use has a strong direct e®ect on hard drug uptake. This propose
that cannabis use may create a need for stronger drugs and/or yield better knowledge of the
drug market (transmission channels 1 and 4). We further explore these issues in our sensitivity
analysis in Section 6.
4.2 Results from Predictive Analysis
We employ the predictive analysis to explore the importance of accessibility and proneness
related factors, in addition to that of previous cannabis intake, on a subject's probability of hard
drug uptake. We ¯rst investigate the e®ects for a random (average) subject from the population.
As described in Section 3.3 we focus on the marginal predictive probability of hard drug uptake
under no and previous cannabis use, Pr(h0;n+1 = 1jc;h;W) and Pr(h1;n+1 = 1jc;h;W). From
the ¯rst row in Table 3 we see that the subject's probability to take up hard drugs is 7.6% under
no previous cannabis use and 36.2% under previous cannabis use. These two probabilities refer
to the two counterfactual scenarios if we were to observe the same random subject from the
population under no and previous cannabis use. The estimates are based on the marginal model
of hard drug uptake and are corrected for unobserved confounding (selection on unobservables).
If we assume that we have successfully accounted for all unobserved confounders through our
°exible joint model, the di®erence of 28 percentage points can be interpreted as the causal e®ect
of cannabis use on hard drug uptake.
Table 3 also reports the estimated marginal predictive probabilities without the e®ect of
accessibility, price and proneness factors as well as the direct \gateway" e®ect (under previous
cannabis use only). As discussed in Section 3.3, these \partial" probabilities are obtained by
22Predictive Probabilities for Extended Gateway Model
informed prior ignorant prior
no cannabis cannabis no cannabis cannabis
Total Pr(hj;n+1 = 1) 0.076 0.362 0.081 0.351
Partial w/o Access* 0.036 0.164 0.040 0.136
w/o Prices 0.053 0.363 0.060 0.350
w/o Gateway - 0.094 - 0.130
w/o Proneness 0.035 0.257 0.036 0.243
Table 3: Estimates for total and partial marginal predictive probabilities of hard drug uptake based
on the extended gateway model under two di®erent prior assumptions. The informed prior the uses
information from the 2002. Under the ignorant prior the prior distributions for all parameters are
centered at zero. *Access includes all access related variables from main speci¯cation other than
prices.
setting the corresponding coe±cients to zero. From these we can then compute the average
marginal e®ects. For example, the e®ect of the accessibility factors for non-users is 4 percentage
points (7.6% - 3.6%). Under previous cannabis use, the average marginal e®ect of accessibility
factors is considerable higher with 19.8 percentage points due to the extended gateway e®ect.
The largest average marginal e®ect is that of the constant gateway e®ect with 26.8 percentage
points. Without the constant gateway e®ect, the probability of hard drug initiation under
cannabis user reduces to 9.4 % and comes close to that under no previous use of 7.6%. Finally,
as expected from the estimates of the price coe±cient the e®ect of prices is the smallest.
Finally, we also report the predictive results for the analysis of the extended gateway model
under alternative prior assumptions that are not based on the 2002 data (ignorant prior) in
Table 3. The estimates of the predictive probabilities as well as those of the model parameters
(see Table 11 in appendix) are comparable to those from the analysis under the informed priors.
We do observe a smaller decrease in the probability due to the direct gateway e®ect as result of
the smaller mean of the posterior distribution for the constant e®ect of previous cannabis use
(as shown in Table 2). Overall the estimates in Table 3 suggest that accessibility and proneness
also play an important role in subject's hard drug initiation. Both proneness and accessibility
have a larger e®ect on the probability of hard drug uptake for cannabis user, which contributes
to the observed pattern of higher hard drug use among cannabis users. Since we can only assess
the e®ects based on the available limited data on proneness and accessibility, it is very likely
23that our estimates should be interpreted as a lower bound of the e®ects. We also note that
especially the e®ect of accessibility related variables is much higher under previous cannabis
use. This is to a large extent driven by the di®erent coe±cient estimates on accessibility factors
under the two cannabis use states that we showed in previous section. We further observe a
larger marginal average e®ect of proneness under previous cannabis use which is a result of the
non-linear transformation of in the probit model.
Another approach to evaluate the importance of the three factors is to investigate the ef-
fects of changes in the three factors on hard drug initiation. Here we consider a number of
di®erent scenarios, for example an increase or decrease in drug supply or prices. We begin
again by examining the implications for the marginal predictive probabilities of hard drug ini-
tiation Pr(hj;n+1 = 1jc;h;W) where j = 0;1 refers to assumed previous cannabis use. The
results are given in the second and third columns of Table 4. To estimate how these scenar-
ios would a®ect the overall hard drug initiation in the population (with and without previ-
ous cannabis use), we also report the predictive conditional probability of hard drug initiation
Pr(hj;n+1 = 1jcn+1;c;h;W) under the di®erent scenarios in the last column of Table 4. This
measure is based on the joint probability of cannabis and hard drug initiation and takes into
account a subject's probability of previous cannabis use (see appendix for estimation).
We ¯rst consider a scenario where the availability of hard drugs (measured by seizure and
prevalence) will change in response to policy interventions. Our results suggest that a 50%
decrease in availability would reduce the overall probability of hard drug uptake from 0.134 to
0.086 (see last column of Table 4). As expected, an higher accessibility will have the opposite
e®ect, increasing the overall probability from 0.134 to 0.165. While changes in accessibility to
hard drugs have almost no e®ect non-users of cannabis (both in estimation model and prediction
results), the impact on cannabis users is non-trivial.
We further examine two di®erent scenarios for changes in the proneness variables. If the
sample prevalence of problems with parents and police doubles, the overall probability of hard
drug initiation increases to 0.144, while setting the two problem variables to zero reduces the
corresponding probability to 0.116. A successful policy towards reducing early alcohol initiation
24Predicted Hard Drug Uptake for Policy Scenarios
No Cannabis Cannabis Overall
Base 0.076 0.362 0.134
high hard drug seizure and prevalence 0.076 0.545 0.165
low hard drug seizure and prevalence 0.074 0.236 0.086
more problems with police and parents 0.085 0.378 0.144
no problems with police and parents 0.067 0.341 0.116
more early alcohol use and leave school 0.083 0.377 0.151
no early alcohol use and leave school 0.068 0.346 0.124
high can prevalence - - 0.156
low can prevalence - - 0.116
high can price - - 0.129
low can price - - 0.137
high constant gateway e®ect - - 0.188
lower constant gateway e®ect - - 0.089
Table 4: Predicted probabilities for di®erent possible policy scenarios based on the extended gateway
model.
and school drop-outs would have a somewhat smaller e®ect and reduce the overall probability
to 0.124. Note that these changes are based only on the model for hard drug intake and do not
directly consider the interaction between cannabis and hard drug use. This means that if the
policy scenarios discussed here also in°uence the probability of cannabis uptake, the results are
likely to underestimate the overall e®ect on hard drug use in the population.
Given the link between cannabis and hard drug use, however, an interesting policy question
is how changes in the accessibility to cannabis would a®ect hard drug initiation. By employing
the conditional predictive probability of hard drug uptake (instead of the marginal predictive
probability), we can explore this question. Lowering the prevalence of cannabis use by 50%
(everything else held constant) would decrease the probability of hard drug uptake from 0.134
to 0.116, while a 50% increase in the prevalence raises the probability to 0.156. Changes in the
cannabis price, on the other hand, only have a very small e®ect on the overall probability of hard
drug uptake. Lastly, we consider a change in the strength of the direct e®ect of previous cannabis
use. For instance, a policy aiming at separating the markets for cannabis and hard drugs (in line
with what is found in the Netherlands), may reduce the e®ect previous cannabis use has on hard
drug initiation if the policy change reduces the social interaction between di®erent groups drug
users (mechanism 4 of those listed in section 1). In contrast, a more profound gateway e®ect
25than the one estimated here, is an alternative possible future scenario as improved cultivation
techniques have resulted in cannabis with higher THC levels, i.e. more potent cannabis. More
potent cannabis could imply stronger addiction to the drug and more craving also for other, and
stronger, drug experiences (mechanism 1 in section 1). According to the World Drug Report
2007 (UN 2007), the prevalence of this high-potent cannabis has increased substantially in
recent years. The last two rows of Table 4 show that a 50% decrease/increase in the coe±cient
on previous cannabis use are the scenarios with the largest e®ect on hard drug initiation. A
decrease will reduce the overall probability of hard drug uptake from 0.134 to 0.089 and an
increase will raise it to 0.188.
5 Sensitivity Analysis
In this section we present selected results from the prior posterior and predictive analysis from
di®erent speci¯cations of the extended gateway model. We consider di®erent frequency de¯ni-
tions of the cannabis and hard drug variables as well as di®erent speci¯cations of the variable
vector in the hard drug equation. The purpose is 1) to check the robustness of our ¯ndings
from the previous section regarding the direct and extended gateway e®ects and the importance
of accessibility, proneness and previous cannabis use for hard drug initiation; and 2) to aid the
interpretation of our results with respect to the transmission channels of previous cannabis use.
In Tables 5 and 6 we provide results from the ¯tting and the predictive analysis of the
extended gateway model under two alternative frequency de¯nitions of the cannabis and hard
drug variables, ci and hi. So far we have de¯ned a cannabis user (ci = 1) as a person that
has used cannabis at least 5 times (and ci = 0 otherwise) and a hard drug user (hi = 1) as a
person who has used hard drugs at least once (and hi = 0 otherwise). Under Speci¯cation 1
we now de¯ne a person as a cannabis user (hard drug users) if he/she has used cannabis (any
hard drug) at least once. Under Speci¯cation 2 we de¯ne a person as cannabis user (hard drug
user) if he/she has used cannabis (any hard drug) at least ¯ve times. We ¯nd that the gateway
coe±cient varies from 0.93 for Speci¯cation 1 to 1.24 for Speci¯cation 2 compared to 1.20 in
the main model. The predicted probabilities for these speci¯cations di®er somewhat more from
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Spec 1 Spec 2 Spec 3
Hard uptake Hard uptake Hard uptake
no can can no can can no can can
Country 0.03 (0.24) 0.23 (0.16) 0.05 (0.24) 0.25 (0.19) 0.13 (0.16) 0.41 (0.17)
Oslo 0.48 (0.34) -0.73 (0.38) 0.27 (0.36) -1.12 (0.50) 0.46 (0.28) -1.06 (0.44)
Obtain 0.21 (1.09) 0.03 (0.91) -0.37 (1.10) -0.18 (1.13) - -
seizure -0.05 (0.78) 2.38 (0.92) 0.25 (0.83) 2.78 (1.19) 0.10 (0.64) 3.00 (1.03)
Prevalence -0.16 (1.34) 2.83 (1.84) 0.03 (1.36) 2.55 (1.99) 0.18 (1.34) 2.15 (1.89)
Non-Western -0.08 (0.22) -0.10 (0.21) -0.22 (0.24) 0.37 (0.27) -0.34 (0.20) 0.60 (0.29)
Amph. Price 0.49 (0.50) -0.08 (0.37) 0.54 (0.55) -0.18 (0.50) - -
Can. Use 0.93(0.48) 1.24(0.57) 1.35(0.51)
Intercept -2.91(0.54) -2.81(0.57) -2.12(0.23)
smoking included included -
Other* included included included
Table 5: Speci¯cations 1 and 2 refer to the main model with the di®erent frequency de¯nitions of
the depended variables, freq11 and freq22. *All speci¯cations include the standard proneness and
demographic variables from the main estimation.
those estimated for the main model (Table 3). However, the di®erences are consistent with the
frequencies in the raw data(see Table 10 in Appendix B). As before, we ¯nd that accessibility and
proneness factors contribute signi¯cantly to hard drug uptake in addition to previous cannabis
use, composed of a direct e®ect and a extended e®ect via the accessibility variables.
We need to acknowledge potential endogeneity issues with respect to some of our control
variables, in particular for the lifetime smoking and the obtain variables, which may bias our
results. To address this concern, we have estimated the extended gateway model without these
variables (Speci¯cation 3). Again we ¯nd that our results do no change dramatically compared to
those in the main model. As expected, the exclusion of the smoking variable from the proneness
vector wp;i leads to a smaller overall e®ect of proneness on hard drug uptake (Table 5). We do
observe a higher total predictive probability of hard drug uptake for cannabis users under this
speci¯cation.
A comparison of the coe±cient estimates (posterior means) from the ¯tting of Speci¯cations
1 in Table 5 to those from the main model in Table 2 yields some interesting insights and
possible interpretations regarding the transmission channels of previous cannabis use on hard
drug uptake. First, we ¯nd that the posterior mean of the coe±cient on previous cannabis
use decreases from 1.20 to 0.90 if we include also low frequent cannabis user (life time use
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Spec 1 Spec 2 Spec 3
no can can no can can no can can
Total 0.057 0.218 0.035 0.246 0.063 0.543
w/o Access 0.040 0.092 0.038 0.142 0.032 0.293
w/o Prices 0.039 0.234 0.024 0.279 - -
w/o Gateway - 0.071 - 0.053 - 0.131
w/o Proneness 0.020 0.128 0.011 0.154 0.050 0.517
Table 6: Predictive probabilities for various speci¯cations of the extended gateway model.
between one and four times) into the group of cannabis users. This observations is coherent
with the fact that one would expect the strength of the transmission channels 1 and 4 to be
lower for incidental and low frequency cannabis users as they have not yet developed a strong
psychological or physiological need for harder drugs and are less knowledgeable about the drug
market. Further, we don't see large changes in the coe±cients on the accessibility variables.
This observations is consistent with the transmission channels 2 and 3 which claim that having
tried cannabis will lower the threshold and perceived risk of using a harder drug. Using cannabis
only once or twice is su±cient for a subject to pass the threshold to illegal drugs and to be less
concerned about their potential harmful e®ects, increasing the probability to take up hard drugs
given the opportunity.
Another issue that we should address here is that of early cannabis use. It has been suggested
in the literature that starting with cannabis very young could reinforce the gateway e®ect.
Animal studies (Ellgren et al. 2007, Fergusson et al. 2006) and twin studies examining same-sex
twin pairs discordant for early cannabis initiation (see e.g. Lynskey et al. 2006) seem to support
this notion. We therefore consider a speci¯cation that extends our main model by including
an additional indicator for early cannabis use in the hard drug model (Speci¯cation 4). The
indicator is 1 if the respondents report to have used cannabis before they turn 16. We ¯nd
that early cannabis use has a positive e®ect on hard drug uptake (0.71). Interestingly we now
observe a lower mean of the posterior distribution of previous cannabis use of 0.60 compared the
estimate of 1.20 for the main speci¯cation (Table 2). One might speculate that this implies that
the estimated direct gateway e®ect is to a large extent driven by early cannabis use. However,
the early use variable might be associated with endogeneity issues as we cannot rule out that
28early use is at least partially driven by unobserved proneness factors that also drive hard drug
uptake. If, on the other hand, the early use coe±cient re°ects mainly unobserved proneness that
for some reason has not been captured by our joint modeling, then this would imply a smaller
gateway e®ect than the one presented in Table 2. Finally, we should note that the inferences of
the other coe±cients remain fairly stable and we again observed an extended gateway e®ect.
6 Discussion
Extensive use of hard drugs is associated with substantial health risks and adverse consequences
for educational achievements, social relationships, employment and careers. Most countries
therefore rely on a drug policy aiming to reduce the use and misuse of substances such as
cocaine, amphetamine, ecstasy and heroin and many uphold a strict cannabis regime to lower
hard drug use. However, as pointed out in recent literature (e.g. Fergusson et al. 2006, Kandel
et al 2006), the mechanisms which could drive the relationship between previous cannabis use
and hard drug use are not well understood and require empirical investigations. In addition, the
e±cacy of drug policy to reduce hard drug use will depend also on the role of accessibility and
proneness factors. Thus, a better understanding of the factors in°uencing hard drug uptake is
needed to improve drug policy means.
Using data from a representative sample of Norwegian adults (21-30 years) and a novel
modeling approach, this paper examines the in°uence of previous cannabis use, accessibility and
proneness factors on the probability of hard drug uptake. To the best of our knowledge, this
paper is the ¯rst attempt in the literature to examine the three hypotheses simultaneously and to
quantify the relative importance of the three e®ects on the probability of hard drug uptake. Our
results show that all three factors matter, with the e®ect of previous cannabis use dominating the
e®ects from the observed accessibility and proneness factors. Our predictive analysis suggests
that, for a random person, the probability of taking up hard drugs increases from roughly 8
per cent, if he/she has not previously used cannabis, to 36 per cent for cannabis users. Both
proneness and accessibility have larger e®ects for cannabis users than for non-cannabis users,
with the overall e®ects (measured as marginal average e®ects) from accessibility being more
29important than those of proneness. This is partly due to the fact that even though many of the
proneness variables proved important, relatively few individuals reported problems with police
and parents or started to drink alcohol before they turned 13. As shown in the sensitivity
analysis, our general ¯ndings are robust across various model speci¯cations (e.g. alternative
de¯nitions of the dependent variables and sets of covariates).
We have proposed an extended gateway model for hard drug initiation that is motivated by
four transmission channels of cannabis use on hard drug initiation. The model allows us to gain
some insights about the suggested transmission mechanisms that could underpin the gateway
e®ect of cannabis that we further explore in our sensitivity analysis. Channel 1 suggests that (i)
cannabis causes a psychological and/or physiological need for stronger drug experiences re°ected
in a positive constant gateway e®ect and (ii) that the e®ect increases with a higher frequency of
cannabis use. In line line with (i) we ¯nd a positive coe±cient on previous cannabis use in our
main model speci¯cation. As suggested by (ii) the coe±cient decreases if we include \incidental"
cannabis users (Speci¯cation 1).
The second and third mechanisms refer to a lower credibility in warnings and reduced costs
of trying another drug after personal illegal drug experience, and imply a lower threshold for
hard drug use after cannabis has been initiated. While a more restricted hard drug model,
with only a dummy for previous cannabis use, cannot isolate potential threshold e®ects, we ¯nd
support for the hypothesis in terms di®erent e®ects of the accessibility variables for cannabis
users versus non-users in our extended gateway model. Given the same degree of physical
accessibility, cannabis users, who have passed the threshold and thus face lower costs of hard
drug initiation, are more likely to take up hard drugs. The coe±cients on accessibility show little
variation across the models with di®erent frequency speci¯cations of the drug use variables. This
indicates that once a subject has passed the threshold to illegal drug use, frequency of use is not
of great importance for the accessibility e®ects as one would expect.
Finally, without being able to include any variables re°ecting individual variation in social
interaction or market knowledge in the estimations, the fourth mechanism is hard to examine
separately. The constant gateway e®ect we report may re°ect this transition channel but will
30also re°ect psychological and/or physiological e®ects (channel 1). As mentioned earlier, the
raw data strongly suggest that there are di®erences between cannabis users and non-users with
regard to reported obtainability of hard drugs. Table 9 presented in Appendix B shows that only
31, 23, 19 and 29 per cent of non-users claim to be able to obtain amphetamine, cocaine, heroin
and ecstasy, respectively, within three days. The corresponding numbers for cannabis users are
62, 57, 33 and 48 per cent. Also, more cannabis users report that they have been o®ered hard
drugs (80 vs 26%). Probable endogeneity problems restrain us from including these variables in
the estimations. Based on our ¯ndings, however, we would argue that there are support in the
data for all the suggested mechanisms.
With regard to possible policy implications, the ¯nding of a substantial gateway e®ect sug-
gests that any intervention successful in reducing cannabis use also will have a positive e®ect on
the uptake of hard drugs. Previous cannabis use is the single most important variable for the
increased probability of starting to use drugs like amphetamine and cocaine. Further, for any
given level of cannabis use, means for weakening the transition mechanisms should be of interest
to policy makers. For instance, a separation of markets for cannabis and hard drugs may prove
e®ective in reducing hard drugs uptake if that would reduce the in°uence hard drug users and
knowledge of those markets might have on current cannabis-only users. Increased credibility of
health warnings, something which might be achieved by providing more drug speci¯c informa-
tion instead of focusing on illegal drugs in general, is another means to weaken the transition
mechanisms. The recent increase in the prevalence of high-potent cannabis may, on the other
hand, strengthen the e®ect of cannabis use. Further, our ¯ndings regarding observed proneness
factors indicate that intervention directed against high risk groups, e.g. early detection and
adequate interference towards subgroups with high prevalence of the problem indicators (early
alcohol debut, low educational achievements, problems with parents and police), will reduce
hard drug initiation.
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337 Appendix A: Model Estimation
7.1 Prior Speci¯cation
To specify the hyper-parameters in the prior distribution given by equation (3.5) for the esti-
mation we exploit data from the 2002 survey on drug use. We ¯rst ¯t the model described in
Section 3.1 without the nonwest and hard drug price variables in the vector wah;i and without
the cannabis price variable in wac;i as we have insu±cient information for these in the 2002 data.
Otherwise the covariate vectors are de¯ned as speci¯ed in Section 3.1. The means of the prior
distributions are centered at zero to express our apriori ignorance and the prior variances are
set to 5 for the slope parameters and 1 for the correlation parameters to ensures su±cient prior
°exibility. The ¯tting leads to the following posterior means for the coe±cients in the hard drug
and cannabis equations:
^ ¯0;2002 = (¡0:11;¡0:36;¡1:04;1:61;¡0:28;0;0)
^ ¯1;2002 = (0:66;¡0:43;¡1:40;2:21;1:0;0;0);
^ ®2002 = (¡1:78;1:29;0:78;0:18;0:32;¡0:24;0:62;0:44;0;0:10;0:15);
^ °2002 = (¡1:22;¡0:35;0:04;0:08;0:40;0;0;0:64;0:47;0:48;¡0:19;0:06;0:62;0;0:25;0:14):
We take these posterior means to re°ect our updated assumptions about the prior means in the
cannabis and hard drug models after seeing the 2002 data:
b00 = ^ ¯0;2002; b10 = ^ ¯1;2002; a0 = ^ ®2002; g0 = ^ °2002:
The values in b00 and b10 refer to the accessibility variables in wah;i, a0 to the covariate vector
fconst » ci » wp;i » wd;ig and g0 to the covariate vector fconst » ci » wac;i » wp;i »
wd;ig. For example, our speci¯cation of b00 and b10 suggest that accessibility factors a®ect hard
drug initiation, and do so in a di®erent way depending on previous cannabis use. The lower
prior means for the seizure and prevalence variables for subjects without previous cannabis use
(1:61;¡0:28) compared to those with prior use (2:21;1:0) express a prior belief that previous
cannabis a®ects hard drug initiation via transmission channels 2 and 3. The positive prior mean
of 1.29 on the gateway coe±cient assumes that previous cannabis use a®ects hard drug uptake
directly (via transmission channels 1 and/or 4). Note that we have set the prior means of the
non-western and price variables at zero since we cannot update our prior ignorance based on
the 2002 data.
To ensure that our prior assumptions can be updated based on the new data via the likelihood
of the 2006 data, we again formulate °exible priors around these speci¯ed means. In particular,
we set the variances for all slope coe±cient at 2. Based on the 2002 data analysis, we center the
prior distributions of the correlation parameters (½0;½1) at 0.15 and 0 with a variance of 1.
7.2 Algorithm for Prior-Posterior Analysis
Due to the structure of the likelihood function, the posterior distribution ¼(µjh;c;W) of the
vector of model parameters µ = (¯0;¯1;®;°;½0;½1) is not readily estimable via Markov Chain
Monte Carlo (MCMC) methods. We can however, exploit the ideas in Albert and Chib (1993)
and include the latent drug intake variables in the parameter space and work with the augmented
posterior distribution ¼(µ;c¤
i;h¤






34where the joint likelihood of the augmented parameter space p(h;c;h¤
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i · 0g1¡ci + Ifc¤
i > 0gci][Ifh¤
ji · 0g1¡hji + Ifh¤
ji > 0ghji] (7.1)
hi = h0i if ci = 0 and hi = h1i if ci = 1. The prior distribution is given by expression (3.5). The
resulting joint posterior distribution is of a type that can be e±ciently processed by MCMC
methods. We propose the following six step MCMC chain to generate draws from the posterior
distribution. We let c = (c0;c1) where c0 = (ci : i 2 N0) and c1 = (ci : i 2 N1) represent the
cannabis observations under the two possible cannabis states; with a similar convention for the
latent cannabis intake is c¤ = (c¤
0;c¤
1). We propose the following algorithm to generate draws
from the posterior distribution for the extended gateway model proposed in Section 3.1-2. The
algorithm is run for M (for example M = 10;000) iterations. A burn-in phase of 1,000 iterations
is used to ensure that MCMC chain has converged to the posterior distribution of interest.
MCMC Algorithm:
1. Initialize ¯j;®;°;½j;fc¤
ig for j = 0;1
2. Sample h¤
j;ijhji;ci;c¤
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4. Sample °jh;c;h¤;c¤;¯;®;½ from Nk(°j^ °;G), where
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1;°;½ from Np(¯j^ ¯;B), where





















1;°;½ from Nm(®j^ ®;A), where


















j;¯j;°, for j = 0;1 from an MH step described below.
8. Goto 2
35Since the full conditional distribution of the correlation coe±cient ½j is not tractable, we
update the parameters using the Metropolis Hastings algorithm. Following Chib and Greenberg
(1995, 1998) we generate proposal values ½0
j from a tailored student-t density tº(¹j;Vj) where







and V is the inverse Hessian of this density evaluated at ¹j. We accept the proposal value with

















7.3 Extended Algorithm for Predictive Analysis
The marginal predictive probabilities of hard drug use Pr(hj;n+1 = 1jc;h;W), j = 0;1 can be
computed based on the predictive distributions of the latent hard drug intake. To generate
draws from p(h¤
j;n+1jh;s;W;wh;n+1) we exploit the fact that the conditional predictive distri-
bution p(h¤
j;n+1jh;s;W;wh;n+1;¯j;®) is of a known form. To obtain the marginal predictive
distribution we integrate numerically over the parameters using the corresponding posterior dis-
tribution and over wh;n+1 using the empirical distribution of the data. This can be done in a
straight forward manner by extending the model ¯tting algorithm, that generates draws of the

















j and ®(g) are the parameter
values at the current g'th iteration of the MCMC algorithm
² Store values
The resulting draws [h¤1
j;n+1;h¤2
j;n+1;:::;h¤M
j;n+1] are from the marginal predictive distribution of
latent hard drug intake. From these draws we can immediately compute the probabilities of
hard drug intake as







To compute the partial predictive probabilities without accessibility e®ects etc we use the same










To compute the overall probability of hard drug use in Table 4, which is based on the




























The draws on h
(g)
j;n+1 are then used to compute Pr(hj;n+1 = 1jcn+1;c;h;W).
378 Appendix B: Additional Data Summaries and Estimation Re-
sults
Distribution of Hard Drug Use
Amphetamine Cocaine Ecstacy Heroin
# of hard drugs used (n = 419) (n = 419) (n = 294) (n = 63)
1 19% 21% 11% 3%
2 31% 30% 19% 8%
3 38% 37% 53% 11%
4 12% 12% 17% 78%
Table 7: Percentage of amphetamine, cocaine, ecstacy and heroin users that used 1, 2, 3 or 4 hard
drugs.
Distribution of Problem Variables
Police Parents School Friends Any Problem
# of problems (n = 61) (n = 359) (n = 245) (n = 161) (n = 584)
1 36% 61% 38% 36% 68%
2 38% 24% 39% 33% 22%
3 13% 13% 20% 26% 8%
4 13% 2% 3% 5% 2%
Table 8: Percentage of subjects with problems with police, parents, school and friends that reported
only this one, 2, 3 or all 4 problems.
Obtainability of Drugs by Cannabis Intake
Variable No Cannabis Use Cannabis Use
(n = 3191) (n = 973)
obtain amphetamine 0.31 0.62
obtain cocaine 0.23 0.57
obtain heroin 0.19 0.47
obtain ecstacy 0.29 0.48
Table 9: Means of obtain indicators (1 indicates that subjects can obtain the drug within 3 days)
for various hard drugs in the data by cannabis intake.
38Cannabis and Hard Drug Use under di®erent Frequency Cut-o®s
User De¯nitions No Cannabis Use Cannabis Use only Hard Drug Use
Cannabis Hard Drugs
freqc ¸ 1 freqh ¸ 1 2548 1045 571
freqc ¸ 5 freqh ¸ 1 3089 504 696
freqc ¸ 5 freqh ¸ 5 3160 661 343
Table 10: Drug Use in the sample based on di®erent frequency of use de¯nitions. The second
de¯nition is the one used in the main empirical section, while the one in line 1 refers to Speci¯cation
1 in the sensitivity section and line 3 to Speci¯cation 2 in the sensitivity section.
Extended Gateway Model with ignorant priors
Hard uptake Can uptake
no can can
Country 0.03 (0.18) 0.37 (0.18) -0.29 (0.10)
Oslo 0.58 (0.26) -1.11 (0.46) -0.02 (0.11)
Obtain 0.63 (0.98) 0.23 (1.06) 0.06 (0.71)
Seizure -0.37 (0.64) 3.21 (1.11) -
Prevalence 0.43 (1.30) 2.53 (1.97) 2.09 (0.90)
Non-Western -0.31 (0.19) 0.48 (0.29) -0.54 (0.13)
Amphetamine Price 0.36 (0.41) 0.04 (0.44) -
Cannabis Price - - -0.75 (1.38)
Cannabis Use 0.93 (0.54) -
Police prob. 0.88 (0.22) 0.61 (0.19)
Parents prob. 0.46 (0.10) 0.42 (0.08)
School prob. 0.03 (0.13) 0.25 (0.11)
Friends prob. -0.04 (0.16) -0.09 (0.13)
Leave School early 0.51 (0.12) 0.18 (0.11)
Alcohol young 0.29 (0.11) 0.40 (0.09)
Smoker 0.44 (0.16) 1.17 (0.06)
Male 0.29 (0.07) 0.43 (0.05)
Age2124 -0.02 (0.10) 0.02 (0.06)
Intercept -2.70 (0.47) -2.16 (0.39)
Correlation 0.37 (0.24) 0.08 (0.21)
Table 11: Posterior means and standard deviations (parentheses) of the model parameters from the
prior posterior analysis of the extended gateway model and for the restricted gateway model (selected
results only). Results are based on the prior assumptions informed by the 2002 data as discussed in
Section 4.2.
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